At Shorla Oncology we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population. Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments.Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.

Enterprise Ireland

Seroba Life Sciences

Shorla Oncology

Incyte is a pharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics.

Incyte

Syndax is a clinical-stage biopharmaceutical company focused on developing therapies for various cancer indications.

Syndax

Immunocore is a biotechnology company specializing in the development of novel T cell receptor-based immunotherapies for cancer.

Immunocore

Fog Pharmaceuticals is a biopharmaceutical company dedicated to developing novel therapeutics for cancer and other diseases.

Fog Pharmaceuticals

Mereo BioPharma is a biopharmaceutical company focused on the development of innovative therapies for rare diseases and cancer.

Mereo BioPharma

Blueprint Medicines is a precision therapy company focused on developing targeted therapies for cancer and rare diseases.

Blueprint Medicines

Shorla Oncology is a pharmaceutical company focused on developing innovative oncology products to address unmet clinical needs. The company aims to improve patient care by providing therapies that are easier to administer and have the potential to reduce side effects.

industry_trends_dossier

news_impact_assignment_basic

key_people

company_dossier

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

network

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

events

strategic_challenges

network_mapping

industry_trends

transactions_dossier

strategic_challenges_dossier

network_onboarding

company_summary

regulatory_analysis

industry_analysis

swot_dossier

competition_analysis

financial_legal_advisories

merger_acquisitions

swot_analysis

financial_analysis

news_advanced

purchaser_profile

news_impact_assignment_advanced

signals

news_processing_advanced

financial_statements

private_financials

funding_rounds_analysis

company_structure

crunchbase_trigger

crunchbase_profile

li_profile

translate_crunchbase_fundingrounds

peers

news_basic

valuation

customer_profile

industry trends dossier	dataroom
company dossier	dataroom
network	dataroom
network mapping	dataroom
transactions dossier	dataroom
network onboarding	dataroom
news impact assignment basic	general
public peers	general	May 11, 2024 7:43 AM	62f627fe
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 11, 2024 3:32 PM	6ca4b6c7
company summary	general
news advanced	general
news impact assignment advanced	general
signals	general
news processing advanced	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 11, 2024 7:43 AM	c27f48cb
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 11, 2024 7:43 AM	fca2a251
events	markdown
bundesanzeiger	filings
regulatory analysis	company_analysis
industry analysis	company_analysis
competition analysis	company_analysis
financial legal advisories	company_analysis
merger acquisitions	company_analysis
swot analysis	company_analysis
financial analysis	company_analysis
funding rounds analysis	company_analysis
company structure	company_analysis
purchaser profile	merger_acquisitions
private financials	financials
customer profile	customers

COM:SHORLAONCOLOGY

Shorla Oncology